-
Product Insights
Coagulation Factor X – Drugs In Development, 2023
Global Markets Direct’s Coagulation Factor X provides in depth analysis on Coagulation Factor X targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Coagulation Factor X targeted therapeutics...
-
Product Insights
Kappa Type Opioid Receptor – Drugs In Development, 2023
Global Markets Direct’s Kappa Type Opioid Receptor provides in depth analysis on Kappa Type Opioid Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Kappa Type Opioid...
-
Product Insights
Triggering Receptor Expressed On Myeloid Cells 1 – Drugs In Development, 2023
Global Markets Direct’s Triggering Receptor Expressed On Myeloid Cells 1 provides in depth analysis on Triggering Receptor Expressed On Myeloid Cells 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Thromboembolic Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Thromboembolic Disease - Drugs In Development, 2023’, provides an overview of the Thromboembolic Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thromboembolic Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Raynauds Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Raynauds Disease - Drugs In Development, 2023’, provides an overview of the Raynauds Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Raynauds Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Anemia of Chronic Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Anemia of Chronic Disease - Drugs In Development, 2023’, provides an overview of the Anemia of Chronic Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anemia of Chronic Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Behcet Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Behcet Disease - Drugs In Development, 2023’, provides an overview of the Behcet Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Behcet Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Interleukin 1 Beta – Drugs In Development, 2023
Global Markets Direct’s Interleukin 1 Beta provides in depth analysis on Interleukin 1 Beta targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Interleukin 1 Beta targeted therapeutics...
-
Product Insights
Prostaglandin G/H Synthase 1 – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin G/H Synthase 1 provides in depth analysis on Prostaglandin G/H Synthase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin G/H Synthase...
-
Product Insights
Toll Like Receptor 4 – Drugs In Development, 2023
Global Markets Direct’s Toll Like Receptor 4 provides in depth analysis on Toll Like Receptor 4 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Toll Like Receptor...